Ruiqiong Liu
Tianjin Key Laboratory Of Medical Epigenetics
Tianjin, 300070, China
Tianjin, 300070, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Duplicate - Corrigendum to "Everolimus (RAD001) ameliorates vascular cognitive impairment by regulating microglial function via the mTORC1 signaling pathway" [J. Neuroimmunol. 299 (2016) 164-171].
Journal: Journal of neuroimmunology
Published: February 05, 2019
Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis.
Journal: Cell reports
Published: January 25, 2019
Corrigendum to "Everolimus (RAD001) ameliorates vascular cognitive impairment by regulating microglial function via the mTORC1 signaling pathway" [J. Neuroimmunol. 299 (2016) 164-171].
Journal: Journal of neuroimmunology
Published: December 12, 2018
BRMS1 coordinates with LSD1 and suppresses breast cancer cell metastasis.
Journal: American journal of cancer research
Published: August 20, 2018
LSD1 coordinates with the SIN3A/HDAC complex and maintains sensitivity to chemotherapy in breast cancer.
Journal: Journal of molecular cell biology
Published: September 23, 2017
PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77/CRL4B complex to promote tumorigenesis.
Journal: Nucleic acids research
Published: June 25, 2017
MicroRNA-15b Suppresses Th17 Differentiation and Is Associated with Pathogenesis of Multiple Sclerosis by Targeting O-GlcNAc Transferase.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 06, 2016
Everolimus (RAD001) ameliorates vascular cognitive impairment by regulating microglial function via the mTORC1 signaling pathway.
Journal: Journal of neuroimmunology
Published: June 27, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026